Call on more people to volunteer and spread love. China's organ voluntary donation registration exceeds 6.26 million people, but there is still a gap

Release time:Apr 13, 2024 21:24 PM

Today is the 7th China Organ Donation Day, and this year's theme is "With the stars in your eyes, walk under the light.". The theme event hosted by the China Organ Transplantation Development Foundation was held in Shanghai. According to data from the National Health Commission, the number of registered human organ donation volunteers in China has exceeded 6.26 million. Although the number of voluntary donations has been increasing year by year, experts believe that there is still a certain gap compared to developed countries. They call on the whole society to create an atmosphere of voluntary human organ donation, which can allow more lives to be continued. Chen Zhu, President of the Red Cross Society of China, and Qiu Xin, Secretary of the Party Committee of Fudan University, attended.

Human organ transplantation is an important technical means to save critically ill patients. Organ transplantation is not only a professional technical issue, but also involves complex issues in various aspects such as rule of law, politics, society, ethics, and culture. Conducting organ donation and transplantation in a stable and orderly manner is an important symbol of a country's medical development and social civilization progress, as well as a major measure to benefit people's livelihoods and ensure their health. It is a concrete manifestation of adhering to the principle of "putting people first and life first". Data shows that China has completed over 45800 organ donations after the death of citizens, with over 139700 donated organs. According to current data statistics, China has completed 1594 organ donations after the death of citizens in the past three months, an increase of 13% compared to the same period in 2022.

Guo Yanhong, Director of the Medical Emergency Department of the National Health Commission, stated that since the launch of the organ donation pilot work in 2010, China has designed a system from scratch, carried out social mobilization and public publicity, continuously improved the legal construction of human organ donation and transplantation, and established a standardized development, ethical compliance, and work system that is in line with China's national conditions and culture for human organ donation and transplantation; We have formed and continuously improved a human organ donation work system based on the Chinese Red Cross Society, widely carried out publicity and mobilization for human organ donation, encouraged active public participation, carried out voluntary registration for human organ donation, organized commemorative activities, and opened a green channel for the transportation of donated organs to transmit life. The whole society has also achieved scientific and fair distribution of donated organs, established a scientific distribution system for organs, and activated the "Chinese Human Organ Allocation and Sharing Computer System" to automatically allocate organs in accordance with the principles of fairness, impartiality, and openness.

Zhao Hongtao, Chairman of the China Organ Transplantation Development Foundation, told reporters that currently, the number of registered organ donors in China has exceeded 6.26 million. Since 2014, there have been 10000 registrations every year, and up to now, it has reached one million registrations per year, which is a remarkable progress. However, at the same time, the organ donation rate per million people in China in 2022 is 3.98, which is still a certain gap compared to the international advanced level. The proportion of organ donation volunteers in developed countries accounts for 80% of the total population. Only by creating a voluntary donation atmosphere in the whole society can we better meet the needs of more patients for transplantation.

In Shanghai, Zhongshan Hospital affiliated with Fudan University is one of the earliest institutions in China to carry out organ transplantation. Currently, the hospital has achieved comprehensive development in various aspects such as kidney transplantation, liver transplantation, heart transplantation, and lung transplantation. Last year, it completed more than 280 organ transplantation surgeries, ranking among the top in terms of transplant quantity and quality in the country. It also serves as the Shanghai Kidney Transplantation Quality Control Center.

Professor Fan Jia, academician of the Chinese Academy of Sciences and director of Zhongshan Hospital, stated that taking liver cancer as an example, there are 300000 patients in China who are in the final stage of liver disease each year and require liver transplantation to save lives. However, only a few thousand patients complete liver transplantation each year, and it is still difficult to break through this gap. The reason behind this is that there is still a lack of volunteer organ donors. At Zhongshan Hospital, patients who are included in the COTRS system generally need to wait for six months to more than a year before they can successfully undergo liver transplantation. Some patients unfortunately pass away during the waiting process. Encouraging more people to participate in voluntary donations will reignite the hope of life for more patients.

It is reported that the national research on human organ allocation and sharing policies will be launched today. The first stop of the research is in Shanghai. In the near future, we will also delve into medical institutions to form a policy basis for organ transplantation, improve and optimize work mechanisms and systems, promote the expansion of high-quality transplant medical resources and regional balanced layout in China, and promote the healthy, orderly, and high-quality development of organ donation.

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended